Assignee
CYBIN IRL LTD
IE·9 granted patents·17 pending applications·58 citations·filing 2021–2025
Top patents by PatentIndex Score
26 records- 0198US11242318B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Feb 8, 2022·38 cites·53 claims
- 0297US11724985B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Aug 15, 2023·7 cites·12 claims
- 0396US11834410B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Dec 5, 2023·5 cites·10 claims
- 0496US11746088B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2022·Granted Sep 5, 2023·5 cites·11 claims
- 0595US11958807B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Apr 16, 2024·3 cites·9 claims
- 0691US12291499B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2024·Granted May 6, 2025·0 cites·17 claims
- 0791US2025011282A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 0885US12110272B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Oct 8, 2024·0 cites·18 claims
- 0983US2025230128A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2025·Application pending·0 cites
- 1082US2023126298A1Deuyerated tryptamine derivative formulations and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 1179US12240813B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Mar 4, 2025·0 cites·20 claims
- 1277US2025154101A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2025·Application pending·0 cites
- 1366US2024425451A1Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 1465US2025082607A2Methods of treating disorders with a psilocybin analogCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 1562US2025360148A1Solid dispersions of psilocybinCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 1661US12122741B2Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2021·Granted Oct 22, 2024·0 cites·13 claims
- 1760US2025213527A1Formulations of psilocybin analogs and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 1859US2024174607A1Psilocybin analogs, salts, compositions, and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 1958US2024261306A1Formulations of psilocybinCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 2058US2025205198A1Methods for delivery of psychedelic medications by inhalation and systems for performing the methodsCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 2155US2025236589A1Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 2253US2025145566A1Phenethylamine derivatives, compositions, and methods of useCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 2352US2024366655A1Combination drug therapiesCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 2452US2023355583A1Methods for delivery of psychedelic medications by inhalation and systems for performing the methodsCYBIN IRL LTD·Filed 2021·Application pending·0 cites
- 2550US2025051279A1Tryptamine compositions and methodsCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 2637US2024293082A1Integrated data collection devices for use in various therapeutic and wellness applicationsCYBIN IRL LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CYBIN IRL LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →